Markets
Opinion
National
Politics
Companies
Economy
Business
World
Sport
Life
BusinessDay TV
E-Edition
Our Network
07 December 2017
1 Min Read
Sage shares soar as new drug to treat depression aces phase 2 trials
in
Companies
/
Healthcare
by
Akankshita Mukhopadhyay and Divya Grover
Subscribe to our website to read this article and support quality journalism.
If you’ve already subscribed, simply sign in.
Subscribe
Sign In
Related Articles
Companies
Ascendis to buy all of Kyron Labs
Companies
Aspen targets more China partnerships
Companies
Aspen and Equity probes halt in the clear
Companies
Pfizer to review possible separation of its healthcare unit
Companies
Procter & Gamble makes progress but weakness persists in some divisions
Companies
Bayer edges higher as weak consumer healthcare revenues temper drug sales
Companies
Bayer reduces value of Monsanto deal by $2.5bn
Companies
Ascendis seeks R750m capital injection
Loading ...
Loading ...
View Comments